Back to results

University of the Pacific

Ampligen therapy, exercise capacity and immune function in patients with chronic fatigue syndrome

Abstract

dc:description.abstract

<p>Chronic Fatigue Syndrome (CFS) is a debilitating illness that is characterized by pervasive fatigue, sleep disturbance, neurocognitive problems, joint and muscle pain and numerous other symptoms. Results from CFS treatment studies are equivocal. The purpose of this study was to examine the effects of Ampligen® therapy on immune function and functional capacity in a group of patients with CFS. Natural killer cell number and activity, the activity of the 2-SA pathway, and results of serial cardiopulmonary exercise tests were examined for a total of seven subjects (n=7). A key finding was the normalization of RNase L. Only one subject demonstrated both a normalization in RNase L and increase in exercise performance. Trends in NK cell activity were difficult to determine. Improvements in functional capacity as measured by peak V0<sub>2</sub>were seen in five subjects, but these improvements were minor. The expected improvement in both the immune system as measured by RNase L and NK cell function, and improvement in functional capacity were not seen in this study. This confirms that CFS is a very complicated syndrome and that more research is needed. Ampligen® may have been responsible for the RNase L normalization observed in some patients but NK cells seemed unaffected. It could be that Ampligen® is helping the immune system fight viruses present in the CFS subjects. Improvements in peak V02 were small but deconditioning in subjects might be a possible explanation. The exact cause of CFS remains unknown but with continued research it may yet be possible to increase our understanding of CFS.</p>

Degree

thesis:*
Name thesis:degree_name
Master of Arts (M.A.)
Level thesis:degree_level
Thesis - Pacific Access Restricted
Discipline thesis:degree_discipline
Sport Sciences
Year dc:date.available
2003

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Phippen, Shawn G.
Contributors dc:contributor
  • Christopher R. Snell
  • Mark VanNess

Subjects

dc:subject × 4

Rights

dc:rights

Identifiers

dc:identifier.*
Repository record dc:identifier
https://scholarlycommons.pacific.edu/uop_etds/576
OAI identifier oai:identifier
oai:scholarlycommons.pacific.edu:uop_etds-1575

Chain of custody

source
Harvested from
University of the Pacific
Base URL
scholarlycommons.pacific.edu/do/oai/
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
citation

Phippen, Shawn G.. Ampligen therapy, exercise capacity and immune function in patients with chronic fatigue syndrome. Thesis - Pacific Access Restricted thesis, 2003. https://scholarlycommons.pacific.edu/uop_etds/576